Pharmaceuticals, Biotechnology and Life Sciences
DURHAM, N.C.–(BUSINESS WIRE)–JSR Life Sciences, LLC announced today that Dirk Lange will take over as president and chief executive officer…
DURHAM, N.C.–(BUSINESS WIRE)–JSR Life Sciences, LLC announced today that Dirk Lange will take over as president and chief executive officer…
– Gilead Gains Forty Seven’s Investigational Immuno-Oncology Therapy in Multiple Clinical Studies for Diseases Including Myelodysplastic Syndrome, Acute Myeloid Leukemia…
— Q4 2019 net income was $0.07 per basic and diluted share and adjusted non-GAAP net income was $0.49 per…
— Q4 2019 net income was $0.07 per basic and diluted share and adjusted non-GAAP net income was $0.49 per…
KENILWORTH, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today the presentation of…
KENILWORTH, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today the presentation of…
OSAKA, Japan–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the completion of its previously-announced sale of a portfolio of…
IRVINE, Calif.–(BUSINESS WIRE)–$NVUS #otitismedia–Novus Therapeutics, Inc. (NASDAQ: NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders…
IRVINE, Calif.–(BUSINESS WIRE)–$NVUS #otitismedia–Novus Therapeutics, Inc. (NASDAQ: NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders…